Biofil Historical Balance Sheet

BIOFILCHEM

62.15 2.39 4.00%

Trend analysis of Biofil Chemicals Pharmaceuticals balance sheet accounts such as Total Assets of 242.1 M, Short and Long Term Debt Total of 4.2 M or Other Current Liab of 3.9 M provides information on Biofil Chemicals' total assets, liabilities, and equity, which is the actual value of Biofil Chemicals Pha to its prevalent stockholders. By breaking down trends over time using Biofil Chemicals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Biofil Chemicals Pha latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Biofil Chemicals Pha is a good buy for the upcoming year.

Biofil Chemicals Inventory

26.77 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biofil Chemicals Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

About Biofil Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Biofil Chemicals Pha at a specified time, usually calculated after every quarter, six months, or one year. Biofil Chemicals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Biofil Chemicals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Biofil currently owns. An asset can also be divided into two categories, current and non-current.

Biofil Chemicals Balance Sheet Chart

At present, Biofil Chemicals' Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 299.5 M, whereas Total Assets are forecasted to decline to about 242.1 M.

Common Stock Shares Outstanding Total Assets Short Long Term Debt Total Total Current Liabilities Short Term Debt Long Term Debt

Add Fundamental

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of Biofil Chemicals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Biofil Chemicals Pha books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Biofil Chemicals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Biofil Chemicals Pharmaceuticals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Long Term Debt

Long-term debt is a debt that Biofil Chemicals Pha has held for over one year. Long-term debt appears on Biofil Chemicals Pharmaceuticals balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Biofil Chemicals Pharmaceuticals balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Most accounts from Biofil Chemicals' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Biofil Chemicals Pha current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biofil Chemicals Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	4.6M	5.2M	4.4M	4.2M
Total Assets	187.3M	314.1M	470.8M	242.1M

Short Long Term Debt Total Total Assets

Biofil Chemicals balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Current Deferred Revenue	Short Term Debt	Other Liab	Net Tangible Assets
Common Stock Shares Outstanding		-0.39	0.71	-0.18	-0.31	-0.62	-0.77	0.6	-0.29	-0.25	-0.15	-0.66	0.04	-0.16	-0.34	0.99	-0.23	-0.14	0.44	-0.18	-0.34	-0.92	0.04	0.27	-0.25	-0.33
Total Assets	-0.39		-0.73	0.36	0.82	0.81	0.37	-0.75	0.54	0.83	0.47	0.35	-0.27	0.47	0.86	-0.33	0.67	0.42	-0.75	0.8	0.86	0.57	-0.37	-0.72	0.69	0.83
Short Long Term Debt Total	0.71	-0.73		-0.18	-0.61	-0.93	-0.64	0.93	-0.64	-0.61	-0.44	-0.59	0.02	-0.44	-0.73	0.61	-0.66	-0.11	0.87	-0.54	-0.74	-0.76	0.09	0.87	-0.73	-0.85
Other Current Liab	-0.18	0.36	-0.18		0.31	0.27	0.59	-0.12	0.01	0.3	-0.04	0.65	-0.65	-0.04	0.31	-0.21	0.1	0.68	-0.41	0.29	0.28	0.13	-0.89	-0.11	0.35	0.23
Total Current Liabilities	-0.31	0.82	-0.61	0.31		0.52	0.39	-0.77	0.34	1.0	0.76	0.41	-0.24	0.76	0.97	-0.23	0.66	0.35	-0.61	0.99	0.97	0.53	-0.3	-0.6	0.65	0.59
Total Stockholder Equity	-0.62	0.81	-0.93	0.27	0.52		0.55	-0.83	0.7	0.54	0.31	0.5	-0.16	0.31	0.67	-0.54	0.63	0.21	-0.88	0.46	0.68	0.69	-0.19	-0.84	0.75	0.94
Property Plant And Equipment Net	-0.77	0.37	-0.64	0.59	0.39	0.55		-0.52	0.19	0.35	0.1	0.99	-0.45	0.1	0.41	-0.75	0.42	0.46	-0.59	0.29	0.41	0.64	-0.53	-0.32	0.45	0.35
Net Debt	0.6	-0.75	0.93	-0.12	-0.77	-0.83	-0.52		-0.53	-0.77	-0.74	-0.48	0.01	-0.74	-0.85	0.48	-0.72	-0.03	0.81	-0.71	-0.87	-0.77	0.03	0.84	-0.77	-0.83
Retained Earnings	-0.29	0.54	-0.64	0.01	0.34	0.7	0.19	-0.53		0.37	0.14	0.15	-0.1	0.14	0.51	-0.19	0.39	-0.02	-0.51	0.33	0.5	0.32	0.01	-0.71	0.65	0.7
Accounts Payable	-0.25	0.83	-0.61	0.3	1.0	0.54	0.35	-0.77	0.37		0.76	0.38	-0.23	0.77	0.98	-0.16	0.68	0.33	-0.63	1.0	0.98	0.47	-0.3	-0.65	0.68	0.62
Cash	-0.15	0.47	-0.44	-0.04	0.76	0.31	0.1	-0.74	0.14	0.76		0.11	0.03	1.0	0.74	-0.04	0.54	-0.14	-0.39	0.77	0.77	0.48	0.11	-0.47	0.54	0.45
Non Current Assets Total	-0.66	0.35	-0.59	0.65	0.41	0.5	0.99	-0.48	0.15	0.38	0.11		-0.52	0.11	0.42	-0.63	0.46	0.51	-0.6	0.33	0.43	0.53	-0.61	-0.33	0.49	0.34
Non Currrent Assets Other	0.04	-0.27	0.02	-0.65	-0.24	-0.16	-0.45	0.01	-0.1	-0.23	0.03	-0.52		0.03	-0.2	0.04	-0.28	-0.69	0.2	-0.24	-0.2	-0.03	0.79	0.01	-0.46	-0.18
Cash And Short Term Investments	-0.16	0.47	-0.44	-0.04	0.76	0.31	0.1	-0.74	0.14	0.77	1.0	0.11	0.03		0.74	-0.04	0.55	-0.14	-0.39	0.77	0.77	0.48	0.11	-0.48	0.54	0.45
Net Receivables	-0.34	0.86	-0.73	0.31	0.97	0.67	0.41	-0.85	0.51	0.98	0.74	0.42	-0.2	0.74		-0.24	0.69	0.31	-0.74	0.96	1.0	0.55	-0.25	-0.76	0.76	0.74
Non Current Liabilities Total	0.99	-0.33	0.61	-0.21	-0.23	-0.54	-0.75	0.48	-0.19	-0.16	-0.04	-0.63	0.04	-0.04	-0.24		-0.12	-0.2	0.36	-0.09	-0.23	-0.88	0.07	0.14	-0.11	-0.23
Inventory	-0.23	0.67	-0.66	0.1	0.66	0.63	0.42	-0.72	0.39	0.68	0.54	0.46	-0.28	0.55	0.69	-0.12		0.08	-0.66	0.65	0.74	0.37	-0.29	-0.72	0.77	0.72
Other Current Assets	-0.14	0.42	-0.11	0.68	0.35	0.21	0.46	-0.03	-0.02	0.33	-0.14	0.51	-0.69	-0.14	0.31	-0.2	0.08		-0.35	0.33	0.27	0.06	-0.7	-0.05	0.17	0.17
Other Stockholder Equity	0.44	-0.75	0.87	-0.41	-0.61	-0.88	-0.59	0.81	-0.51	-0.63	-0.39	-0.6	0.2	-0.39	-0.74	0.36	-0.66	-0.35		-0.57	-0.75	-0.51	0.33	0.86	-0.73	-0.89
Total Liab	-0.18	0.8	-0.54	0.29	0.99	0.46	0.29	-0.71	0.33	1.0	0.77	0.33	-0.24	0.77	0.96	-0.09	0.65	0.33	-0.57		0.96	0.41	-0.3	-0.6	0.65	0.57
Total Current Assets	-0.34	0.86	-0.74	0.28	0.97	0.68	0.41	-0.87	0.5	0.98	0.77	0.43	-0.2	0.77	1.0	-0.23	0.74	0.27	-0.75	0.96		0.55	-0.24	-0.77	0.78	0.76
Common Stock	-0.92	0.57	-0.76	0.13	0.53	0.69	0.64	-0.77	0.32	0.47	0.48	0.53	-0.03	0.48	0.55	-0.88	0.37	0.06	-0.51	0.41	0.55		0.0	-0.39	0.4	0.49
Current Deferred Revenue	0.04	-0.37	0.09	-0.89	-0.3	-0.19	-0.53	0.03	0.01	-0.3	0.11	-0.61	0.79	0.11	-0.25	0.07	-0.29	-0.7	0.33	-0.3	-0.24	0.0		0.09	-0.37	-0.2
Short Term Debt	0.27	-0.72	0.87	-0.11	-0.6	-0.84	-0.32	0.84	-0.71	-0.65	-0.47	-0.33	0.01	-0.48	-0.76	0.14	-0.72	-0.05	0.86	-0.6	-0.77	-0.39	0.09		-0.83	-0.93
Other Liab	-0.25	0.69	-0.73	0.35	0.65	0.75	0.45	-0.77	0.65	0.68	0.54	0.49	-0.46	0.54	0.76	-0.11	0.77	0.17	-0.73	0.65	0.78	0.4	-0.37	-0.83		0.85
Net Tangible Assets	-0.33	0.83	-0.85	0.23	0.59	0.94	0.35	-0.83	0.7	0.62	0.45	0.34	-0.18	0.45	0.74	-0.23	0.72	0.17	-0.89	0.57	0.76	0.49	-0.2	-0.93	0.85

Click cells to compare fundamentals

Biofil Chemicals Account Relationship Matchups

Biofil Chemicals balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	423.6M	332.4M	187.3M	314.1M	470.8M	242.1M
Short Long Term Debt Total	11.9M	4.3M	4.6M	5.2M	4.4M	4.2M
Other Current Liab	15.6M	1.4M	1.6M	933K	2.9M	3.9M
Total Current Liabilities	274.8M	167.5M	14.9M	137.3M	285.2M	299.5M
Total Stockholder Equity	148.8M	161.3M	168.4M	173.0M	182.0M	119.5M
Property Plant And Equipment Net	100.9M	97.8M	94.2M	90.0M	86.2M	99.3M
Net Debt	9.4M	(107K)	3.2M	5.0M	(18.4M)	(17.5M)
Retained Earnings	(350.1M)	(337.7M)	(330.6M)	(128.5M)	(318.3M)	(334.2M)
Accounts Payable	259.2M	158.5M	6.0M	126.5M	275.5M	289.3M
Cash	2.6M	4.4M	1.5M	260K	22.8M	24.0M
Non Current Assets Total	100.9M	97.8M	94.2M	90.0M	86.8M	99.9M
Non Currrent Assets Other	(100.9M)	(37K)	(191K)	(307K)	508K	533.4K
Cash And Short Term Investments	2.6M	4.4M	1.5M	377K	22.8M	24.0M
Net Receivables	299.2M	186.0M	71.8M	205.0M	330.3M	346.8M
Liabilities And Stockholders Equity	423.6M	332.4M	187.3M	314.1M	470.8M	242.1M
Inventory	16.9M	43.4M	12.9M	12.1M	25.5M	26.8M
Other Current Assets	303.2M	793K	7.0M	6.5M	5.5M	5.2M
Total Liab	274.8M	171.1M	18.9M	141.0M	288.8M	303.2M
Total Current Assets	322.7M	234.6M	93.1M	224.1M	384.1M	403.3M
Current Deferred Revenue	(11.9M)	(4.3M)	4.3M	2.3M	1.4M	1.5M
Short Term Debt	11.9M	4.3M	4.6M	2.9M	4.4M	4.2M
Net Tangible Assets	136.5M	148.8M	161.3M	168.4M	193.6M	140.0M
Short Long Term Debt	11.9M	4.3M	4.6M	5.2M	4.4M	4.2M
Property Plant Equipment	100.9M	97.8M	94.2M	90.0M	103.5M	103.6M
Net Invested Capital	160.8M	165.6M	173.0M	178.2M	186.4M	182.9M
Cash And Equivalents	2.6M	4.4M	1.4M	260K	234K	222.3K
Net Working Capital	47.9M	67.1M	78.2M	86.8M	98.8M	71.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Other Information on Investing in Biofil Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biofil Historical Balance Sheet

Biofil Chemicals Inventory

26.77 Million

About Biofil Balance Sheet Analysis

Biofil Chemicals Balance Sheet Chart

Common Stock Shares Outstanding

Total Assets

Total Current Liabilities

Long Term Debt

Biofil Chemicals balance sheet Correlations

Biofil Chemicals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biofil Chemicals balance sheet Accounts

Also Currently Popular

Other Information on Investing in Biofil Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Accounts Payable	+ 1.0	Total Current Liabilities
Total Liab	+ 1.0	Accounts Payable
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Net Receivables
Non Current Liabilities Total	+ 0.99	Common Stock Shares Outstanding
Total Liab	+ 0.99	Total Current Liabilities

Net Tangible Assets	- 0.93	Short Term Debt
Total Stockholder Equity	- 0.93	Short Long Term Debt Total
Common Stock	- 0.92	Common Stock Shares Outstanding
Net Tangible Assets	- 0.89	Other Stockholder Equity
Current Deferred Revenue	- 0.89	Other Current Liab
Common Stock	- 0.88	Non Current Liabilities Total